Saturday 17 October 2026
Export NVS’s income statement to Excel — free account
Novartis AG
NVS Healthcare Drug Manufacturers General
Novartis AG’s revenue for fiscal 2025 (year ended December 2025) was $56.7 billion, up 9.57% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS fell 17.4%, free cash flow fell 15.5% and total debt rose 52.9%, each against the same quarter a year earlier. Dividend growth for five consecutive years, revenue growth for three, operating cash flow growth for three.
150.62
0.24
+0.16%
Follow NVS
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
19.15 | 16.47 | 14.05 | 28.91 | 8.16 | 26.60 | 18.53 | 14.16 | 103.59 | 40.05 |
Piotroski F-Score |
8 | 6 | 5 | 6 | 8 | 5 | 7 | 7 | 8 | 5 |
P/S ratio |
4.72 | 3.80 | 4.50 | 4.63 | 3.71 | 4.31 | 4.46 | 3.87 | 0.00 | 0.00 |
Altman Z-Score |
4.13 | 3.61 | 3.85 | 3.42 | 3.38 | 3.05 | 3.40 | 2.90 | 3.20 | 3.10 |
Altman Z″-Score (non-manufacturers) |
3.35 | 3.20 | 3.34 | 3.62 | 4.13 | 2.62 | 3.02 | 3.63 | 3.79 | 3.84 |
P/FCF ratio |
17.34 | 14.06 | 15.10 | 16.32 | 14.99 | 18.64 | 16.44 | 14.21 | 0.00 | 0.00 |
Beneish M-Score |
(2.49) | (2.72) | (2.87) | (2.79) | (2.20) | (2.71) | (2.86) | (2.53) | (2.68) | (2.65) |
P/Operating CF |
118.08 | 46.83 | 82.36 | 48.92 | 50.51 | 53.69 | 61.28 | 47.35 | (26.12) | (21.61) |
Dividend Safety Score |
66 | — | — | — | — | — | — | — | — | — |
P/B ratio |
5.74 | 4.45 | 4.49 | 3.38 | 2.89 | 3.79 | 3.91 | 2.27 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 48.50 | 0.00 | 903.90 | 38.11 | 0.00 | 0.00 |
EV/Sales |
5.10 | 4.11 | 4.71 | 4.79 | 3.73 | 4.80 | 4.78 | 4.22 | (1.40) | (1.25) |
EV/EBITDA |
12.62 | 12.11 | 16.53 | 13.97 | 16.86 | 18.01 | 18.77 | 19.02 | 0.00 | 0.00 |
EV/Operating CF |
15.11 | 12.06 | 15.21 | 14.64 | 13.08 | 17.55 | 17.09 | 13.63 | (5.54) | (5.37) |
EV/FCF |
18.76 | 15.21 | 15.83 | 16.91 | 15.06 | 20.77 | 17.64 | 15.50 | (6.62) | (6.51) |
Quick Ratio |
0.76 | 0.73 | 0.83 | 0.95 | 1.21 | 0.61 | 0.71 | 0.84 | 0.78 | 0.73 |
Current Ratio |
1.12 | 1.04 | 1.16 | 1.29 | 1.51 | 0.90 | 1.04 | 1.20 | 1.21 | 1.12 |
Net Debt/EBITDA |
0.96 | 0.78 | 0.56 | 0.49 | 0.07 | 1.50 | 1.07 | 1.19 | 1.30 | 1.12 |
Debt/Assets |
30.23% | 28.95% | 24.62% | 22.29% | 22.15% | 28.21% | 23.13% | 22.09% | 21.44% | 18.29% |
Debt/Equity |
0.72 | 0.67 | 0.53 | 0.44 | 0.43 | 0.64 | 0.49 | 0.41 | 0.38 | 0.32 |
Asset Turnover |
0.53 | 0.51 | 0.43 | 0.35 | 0.41 | 0.41 | 0.37 | 0.33 | 0.38 | 0.38 |
Operating CF/Net income |
1.37 | 1.48 | 0.97 | 2.05 | 0.63 | 1.69 | 1.16 | 1.13 | 1.64 | 1.71 |
Capex/Depreciation |
(0.71) | (0.60) | (0.07) | (0.27) | (0.36) | (0.35) | (0.07) | (0.33) | (0.34) | (0.33) |
Interest Coverage |
15.42 | 14.46 | 11.43 | 9.93 | 14.41 | 11.68 | 10.69 | 9.02 | 11.11 | 11.69 |
| 30.84% | 26.28% | 27.97% | 10.93% | 38.59% | 14.39% | 17.48% | 16.49% | 10.33% | 8.83% | |
| 13.12% | 11.81% | 13.66% | 5.58% | 18.51% | 6.56% | 8.89% | 9.05% | 5.85% | 5.13% | |
ROIC |
16.10% | 15.08% | 10.72% | 7.45% | 10.64% | 7.82% | 7.94% | 5.54% | 5.78% | 5.68% |
Return on Tangible Assets |
100.14% | 114.05% | 109.15% | 36.57% | 88.79% | 90.93% | 88.15% | 58.24% | 36.22% | 36.55% |
Average Days of Receivables |
58.88 | 53.32 | 58.93 | 69.99 | 57.18 | 61.86 | 64.15 | 71.06 | 64.08 | 61.71 |
Research and Development Expense of Revenue |
19.76% | 19.38% | 24.37% | 21.10% | 18.04% | 18.00% | 19.32% | 18.41% | 17.90% | 18.28% |
Selling, General and Administrative Expense of Revenue |
23.38% | 24.30% | 26.83% | 28.06% | 28.15% | 28.45% | 29.52% | 29.76% | 29.91% | 28.71% |
Intangible Assets out of Total Assets |
0.50 | 0.51 | 0.50 | 0.52 | 0.48 | 0.52 | 0.47 | 0.51 | 0.46 | 0.48 |
Share Based Compensation of Revenue |
1.93% | 2.02% | 1.85% | 1.82% | 1.39% | 1.48% | 1.56% | 1.46% | 1.36% | 1.36% |
Graham Net Nets |
(0.13) | (0.14) | (0.11) | (0.10) | (0.09) | (0.19) | (0.15) | (0.18) | 0.34 | 0.39 |
Graham Number |
62.36 | 53.92 | 60.34 | 44.22 | 85.40 | 44.58 | 52.80 | 64.39 | 0.00 | 0.00 |
Earnings Yield |
5.22% | 6.07% | 7.12% | 3.46% | 12.26% | 3.76% | 5.40% | 7.06% | 0.97% | 2.50% |
Free Cash Flow Yield |
5.77% | 7.11% | 6.62% | 6.13% | 6.67% | 5.36% | 6.08% | 7.04% | (11.87%) | (12.19%) |
Revenue per Share |
29.23 | 25.63 | 22.47 | 19.93 | 23.57 | 21.91 | 21.25 | 19.88 | 21.37 | 20.79 |
Operating CF per Share |
9.87 | 8.73 | 6.96 | 6.53 | 6.72 | 5.99 | 5.95 | 6.15 | 5.38 | 4.83 |
Capex per Share |
(1.92) | (1.81) | (0.27) | (0.88) | (0.88) | (0.93) | (0.19) | (0.74) | (0.88) | (0.85) |
Free Cash Flow per Share |
7.95 | 6.92 | 6.69 | 5.65 | 5.84 | 5.07 | 5.76 | 5.41 | 4.50 | 3.98 |
Cash per Share |
5.98 | 6.67 | 6.95 | 8.68 | 12.63 | 5.08 | 5.00 | 6.88 | 4.04 | 3.27 |
Shareholders Equity per Share |
24.01 | 21.87 | 22.51 | 27.25 | 30.24 | 24.89 | 24.25 | 33.93 | 31.64 | 31.49 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
24.01 | 21.87 | 22.51 | 27.25 | 30.24 | 24.89 | 24.25 | 33.93 | 31.64 | 31.49 |
Free Cash Flow |
15,421.00 | 13,971.00 | 13,897.00 | 12,325.00 | 13,088.00 | 11,533.00 | 13,198.00 | 12,549.00 | 10,566.00 | 9,455.00 |
Working Capital |
3,182.00 | 1,012.00 | 4,091.00 | 8,254.00 | 15,510.00 | (3,386.00) | 1,240.00 | 5,956.00 | 4,805.00 | 2,722.00 |
Capital Expenditures |
(3,723.00) | (3,648.00) | (561.00) | (1,911.00) | (1,983.00) | (2,117.00) | (427.00) | (1,723.00) | (2,055.00) | (2,020.00) |
Net Current Asset Value |
(33,940.00) | (28,416.00) | (22,714.00) | (21,120.00) | (18,255.00) | (41,439.00) | (33,315.00) | (31,308.00) | (30,644.00) | (30,302.00) |
EV/EBIT |
16.40 | 14.61 | 22.52 | 26.22 | 16.86 | 23.59 | 25.63 | 22.80 | 0.00 | 0.00 |
Capex to Sales |
0.07 | 0.07 | 0.01 | 0.04 | 0.04 | 0.04 | 0.01 | 0.04 | 0.04 | 0.04 |
Price to Operating Income |
15.15 | 13.50 | 21.47 | 25.31 | 16.78 | 21.18 | 23.88 | 21.22 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.49 | 0.65 | 0.88 | 0.65 | 0.47 | 0.50 | 0.48 | 0.33 | 0.37 | 0.39 |
Cash ROIC |
16.82% | 16.03% | 16.20% | 11.79% | 10.44% | 11.06% | 13.98% | 9.90% | 9.41% | 8.88% |
Accounts Receivable Turnover |
6.79 | 6.86 | 5.88 | 5.23 | 6.32 | 5.87 | 5.55 | 5.19 | 5.84 | 5.98 |
Accounts Payable Turnover |
3.03 | 2.70 | 2.48 | 2.17 | 2.90 | 2.79 | 2.63 | 2.71 | 3.42 | 3.32 |
Inventory Turnover |
2.28 | 2.20 | 1.91 | 1.67 | 2.30 | 2.31 | 2.23 | 2.10 | 2.62 | 2.81 |
Average Days of Payables |
118.73 | 130.10 | 144.16 | 162.17 | 127.74 | 130.42 | 137.25 | 139.76 | 109.85 | 101.52 |
Days of Inventory on Hand |
167.03 | 162.85 | 173.05 | 226.12 | 153.34 | 172.13 | 151.36 | 174.98 | 145.94 | 130.31 |
Average Receivables |
8,349.00 | 7,544.50 | 7,933.50 | 8,308.50 | 8,369.50 | 8,505.50 | 8,765.00 | 8,888.50 | 8,580.00 | 8,269.00 |
Average Payables |
4,514.00 | 4,749.00 | 5,036.00 | 5,349.50 | 5,478.00 | 5,413.50 | 5,490.00 | 5,362.50 | 5,021.00 | 5,270.50 |
Average Inventory |
5,996.00 | 5,818.00 | 6,544.00 | 6,920.50 | 6,898.50 | 6,556.50 | 6,469.00 | 6,911.50 | 6,561.00 | 6,240.50 |
Average Assets |
106,597.50 | 101,095.50 | 108,699.00 | 124,624.00 | 129,786.50 | 123,074.00 | 131,966.50 | 139,321.00 | 131,601.50 | 130,840.00 |
Average Common Equity |
45,337.50 | 45,438.00 | 53,086.50 | 63,622.50 | 62,244.00 | 56,108.50 | 67,121.50 | 76,459.50 | 74,559.00 | 76,006.50 |
Columns are period end dates